Ethris
Developer of stabilized non-immunogenic mRNA platform designed to develop innovative therapies and vaccines. The company's platform uses a proprietary mRNA-modification technology and lipid nanopartic...
Valuation
$0
Share Price
N/A
Total Raised
$50.5M
Last Round
N/A